Thirteen-month registration of patients with gastroenteropancreatic endocrine tumours in France

Neuroendocrinology

Volumn 89, Issue 2, 2009, Pages 217-222

  Lombard Bohas, C ^a   Mitry, E ^b   O'Toole, D ^c   Louvet, C ^d   Pillon, D ^e   Cadiot, G ^f   Borson Chazot, F ^g   Aparicio, T ^h   Ducreux, M ⁱ   Lecomte, T ^j   Etienne, P L ^k   Cacheux, W ^l   Legoux, J L ^m   Seitz, J F ⁿ   Ruszniewski, P ^c   Chayvialle, J A ^a   Rougier, P ^b  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b HÔPITAL AMBROISE PARÉ   (France)

^c BEAUJON HOSPITAL   (France)

^d HÔPITAL SAINT ANTOINE   (France)

^e CH Bourg en Bresse ^*  (France)

^f SERVICE DE DERMATOLOGIE   (France)

^g HCL   (France)

^h BICHAT HOSPITAL   (France)

ⁱ INSTITUT GUSTAVE ROUSSY   (France)

^j ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^k Clinique Armoricaine St Brieuc   (France)

^l NONE   (France)

^m BORDEAUX UNIVERSITY HOSPITAL   (France)

ⁿ TIMONE HOSPITAL   (France)

more..

Author keywords

Digestive endocrine tumours; Endocrine tumours, epidemiology; Endocrine tumours, France

Indexed keywords

DOXORUBICIN; ENEMA; INTERFERON; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR; STREPTOZOCIN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANUS; APPENDIX; ARTICLE; CARDIA; CHEMOEMBOLIZATION; CHILD; COLON; COMPUTER ASSISTED TOMOGRAPHY; DISEASE REGISTRY; ESOPHAGUS; FEMALE; FRANCE; GASTROENTEROPANCREATIC ENDOCRINE TUMOUR; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; METASTASIS; MULTIPLE ENDOCRINE NEOPLASIA; NEUROENDOCRINE TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS; PANCREAS TUMOR; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECTUM; SAMPLE SIZE; SCHOOL CHILD; SMALL INTESTINE; STOMACH TUMOR; TUMOR LOCALIZATION; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; FEMALE; FRANCE; GASTROINTESTINAL NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEUROENDOCRINE TUMORS; PANCREATIC NEOPLASMS; REGISTRIES; TIME FACTORS;

EID: 61749100328     PISSN: 00283835     EISSN: None     Source Type: Journal    
DOI: 10.1159/000151562     Document Type: Article

References (18)

1. Solcia E, Klöppel G, Sobin L: Histological Typing of Endocrine Tumours, ed 2. Berlin, World Health Organization - International Histological Classification of Tumours, 2000.
2. Williams ED, Sandler M: The classification of carcinoid tumors. Lancet 1963;i:238.
3. Gatta G, Ciccolallo L, Kunkler I, Capocaccia R, Berrino F, Coleman MP, De Angelis R, Faivre J, Lutz JM, Martinez C, Möller T, Sankila R; EUROCARE Working Group: Survival from rare cancer in adults: a population-based study. Lancet Oncol 2006;7:132-140.
4. Lepage C, Bouvier AM, Phelip JM, Hatem C, Vernet C, Faivre J: Incidence and management of malignant digestive endocrine tumours in a well defined French population. Gut 2004;53:549-553.
5. Levi F, Te VC, Randimbison L, Rindi G, La Vecchia C: Epidemiology of carcinoid neoplasms in Vaud, Switzerland, 1974-97. Br J Cancer 2000;83:952-955.
6. Hemminki K, Li X: Incidence trends and risk factors of carcinoid tumors. Cancer 2001;92:2204-2210.
7. Fitzgerald T, Hickner Z, Schmitz M, Seah A, Kort EJ, Richard J: Increasing incidence of nonfunctional neuroendocrine tumors of the pancreas. Gastrointestinal Cancers Symposium, Orlando, 2007, p 147.
8. Corleto VD, Panzuto F, Falconi M, Cannizzaro R, Angeletti S, Moretti A, Delle Fave G, Farinati F, Oncology Study Section of the Italian Society of Gastroenterology: Digestive neuroendocrine tumours: diagnosis and treatment in Italy. A survey by the Oncology Study Section of the Italian Society of Gastroenterology (SIGE). Dig Liver Dis 2001;33:217-221.
9. Halfdanarson T, Rabe K, Rubin J, Peterson M: Pancreatic endocrine tumors (PETs): Incidence and recent trend toward improved survival. Gastrointestinal Cancers Symposium, Orlando, 2007, p 144.
10. Eriksson B, Kloppel G, Krenning E, Ahlman H, Plöckinger U, Wiedenmann B, Arnold R, Auernhammer C, Körner M, Rindi G, Wildi S; Frascati Consensus Conference participants: Consensus guidelines for the management of patients with digestive neuroendocrine tumors - well-differentiated jejunalileal tumor/carcinoma. Neuroendocrinology 2008;87:8-19.
11. Madeira I, Terris B, Voss M, Denys A, Sauvanet A, Flejou JF, Vilgrain V, Belghiti J, Bernades P, Ruszniewski P: Prognostic factors in patients with endocrine tumours of the duodenopancreatic area. Gut 1998;43:422-427.
12. Steinmuller T, Kianmanesh R, Falconi M, Scarpa A, Taal B, Kwekkeboom DJ, Lopes JM, Perren A, Nikou G, Yao J, Delle Fave GF, O'Toole D; Frascati Consensus Conference participants: Consensus guidelines for the management of patients with liver metastases from digestive (neuro)endocrine tumors: foregut, midgut, hindgut, and unknown primary. Neuroendocrinology 2008;87:47-62.
13. Ducreux M, Ruszniewski P, Chayvialle JA, Blumberg J, Cloarec D, Michel H, Raymond JM, Dupas JL, Gouerou H, Jian R, Genestin E, Hammel P, Rougier P: The antitumoral effect of the long-acting somatostatin analog lanreotide in neuroendocrine tumors. Am J Gastroenterol 2000;95:3276-3281.
14. Seitz JF, Dahan L, Rougier P, et al: Preliminary results of a randomized phase III trial comparing streptozotocin plus fluorouracil versus interferon for metastatic carcinoid tumors (FNCLCC - FFCD 9710). J Clin Oncol 2006;24(20 suppl):4090.
15. Ruszniewski P, Rougier P, Roche A, Legmann P, Sibert A, Hochlaf S, Ychou M, Mignon M: Hepatic arterial chemoembolization in patients with liver metastases of endocrine tumors. A prospective phase II study in 24 patients. Cancer 1993;71:2624-2630.
16. Roche A, Girish BV, de Baere T, Baudin E, Boige V, Elias D, Lasser P, Schlumberger M, Ducreux M: Trans-catheter arterial chemoembolization as first-line treatment for hepatic metastases from endocrine tumors. Eur Radiol 2003;13:136-140.
17. Nilsson O, Van Cutsem E, Delle Fave G, Yao JC, Pavel ME, McNicol AM, Sevilla Garcia MI, Knapp WH, Kelestimur F, Sauvanet A, Pauwels S, Kwekkeboom DJ, Caplin M; Frascati Consensus Conference, European Neuroendocrine Tumor Society: Poorly differentiated carcinomas of the foregut (gastric, duodenal and pancreatic). Neuroendocrinology 2006;84:212-215.
18. Mitry E, Baudin E, Ducreux M, Sabourin JC, Rufie P, Aparicio T, Lasser P, Elias D, Duvillard P, Schlumberger M, Rougier P: Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin. Br J Cancer 1999;81:1351-1355.